This trial is active, not recruiting.

Condition breast cancer
Sponsor University of Michigan Cancer Center
Start date March 2009
End date May 2011
Trial size 120 participants
Trial identifier NCT00858585, HUM 22831, UMCC 2008.066


This study will examine genes in three different tissues and look for similarities and differences between normal cells and cancer cells. The tissues to be studies come from blood, lymph node and cancer.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective prospective

Primary Outcomes

Single nucleotide polymorphisms
time frame: time-independent

Eligibility Criteria

Female participants at least 18 years old.

Inclusion Criteria: - Age at least 18 years of age - Able to read and sign the informed consent - Able to provide specimens: one blood draw for white blood cells, provide permission to use tissue already collected.

Additional Information

Official title Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
Principal investigator Catherine Van Poznak, MD
Description Subjects will be given an informed consent to read and sign The medical chart will be reviewed for diagnosis and treatment history Blood (about 4 tablespoons) will be drawn at a clinically available time. The lymph node and breast tumor tissue in the University of Michigan pathology repository will be used for research purposes
Trial information was received from ClinicalTrials.gov and was last updated in March 2016.
Information provided to ClinicalTrials.gov by University of Michigan Cancer Center.